Hexagon Capital Partners LLC Cytosorbents Corp Transaction History
Hexagon Capital Partners LLC
- $546 Million
- Q4 2024
A detailed history of Hexagon Capital Partners LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 3,333 shares of CTSO stock, worth $4,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,333
Previous 3,333
-0.0%
Holding current value
$4,332
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
15.7MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$4.02 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$3.62 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.53 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$2.19 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.62 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $56.7M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...